Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00579410 · ClinicalTrials.gov registry record

Comparison of Acid Reflux at Two Levels in the Esophagus Using the BRAVO Capsule

A clinical trial, sponsored by VA Office of Research and Development.

Completed
Registry status
85
Enrollment target

NCT00579410: Completed study, sponsored by VA Office of Research and Development.

NCT00579410 is a clinical trial that has completed, run by VA Office of Research and Development. The registered enrollment target is 85 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00579410 has completed, sponsored by VA Office of Research and Development.

COMPLETED
Registry status
85 participants
Enrollment target

Study Summary

The purpose of this research is to study the level of acid exposure above the gastroesophageal junction and the distal esophagus in patients with reflux symptoms using a capsule type acid measurement system. Patients with reflux symptoms are likely to have more acid reflux just above the junction of the stomach and the esophagus that may help to improve the diagnosis of gastroesophageal reflux disease (GERD). This may help better treat the reflux symptoms.

Trial Details

FieldValue
Enrollment Target 85 participants
Start Date 2004-05
Est. Completion 2009-10

Sponsor

VA Office of Research and Development

1,668 total trials

What the Registry Record Tells You About NCT00579410

The ClinicalTrials.gov registry entry for NCT00579410 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 85 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT00579410 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00579410 about?

NCT00579410 is a clinical study titled "Comparison of Acid Reflux at Two Levels in the Esophagus Using the BRAVO Capsule". The purpose of this research is to study the level of acid exposure above the gastroesophageal junction and the distal esophagus in patients with reflux symptoms using a capsule type acid measurement system. Patients with reflux symptoms are likely to have more acid reflux just above the junction of...

What is the current status of trial NCT00579410?

This trial is currently completed. The enrollment target is 85 participants. The study started on 2004-05. Estimated completion is 2009-10.

Who is sponsoring clinical trial NCT00579410?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.